Viewing Study NCT00003561


Ignite Creation Date: 2025-12-24 @ 12:24 PM
Ignite Modification Date: 2025-12-28 @ 11:17 AM
Study NCT ID: NCT00003561
Status: TERMINATED
Last Update Posted: 2011-07-20
First Post: 1999-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module